A new study has raised serious concerns over the link between COVID-19 vaccines and an increased risk of cerebral thrombotic syndromes, including strokes. Published in the International Journal of Innovative Research in Medical Science, the research analyzes adverse events (AEs) of cerebral thromboembolism (CTE) following COVID-19 vaccinations. The study, authored by Claire Rogers, James A. Thorp, Kirstin Cosgrove, and Peter A. McCullough, underscores the alarming rise in stroke cases linked to these vaccines.
The study compares data from the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) Vaccine Adverse Event Reporting System (VAERS). The authors analyzed cases reported between January 1, 1990, and December 31, 2023. Over the past three years, there were 5,137 reports of CTE following COVID-19 vaccinations. In contrast, only 52 cases were reported after influenza vaccines over 34 years, and 282 cases were attributed to all other vaccines over the same period.
The study reveals that the rate of cerebral thromboembolism events following COVID-19 vaccination is significantly higher compared to both influenza vaccines and all other vaccines. The proportional reporting ratios (PRRs) for COVID-19 vaccines compared to influenza vaccines were found to be substantial—1120 times greater for CTE and 207 times higher than for all other vaccines.
One critical finding from the study is the gender disparity in the occurrence of cerebral venous thromboembolism (CVT), a rare type of stroke. CVT cases were predominantly reported in females, with a female-to-male odds ratio of 1.63. The research also highlighted that cerebral venous thromboembolism was far more common than cerebral arterial thromboembolism, which showed a slight male preponderance.
Atrial fibrillation, a known risk factor for cerebral arterial thromboembolism, occurred much more frequently in individuals who received the COVID-19 vaccine compared to other vaccines, with a PRR of 123. This finding suggests that the COVID-19 vaccine may have a distinct impact on heart rhythm, potentially leading to an increased risk of stroke.
The study’s findings have raised urgent concerns about vaccine safety, particularly in light of the disproportionately high number of stroke reports following COVID-19 vaccinations. The authors warn that this breach in safety signals presents an unacceptable risk, urging an immediate global moratorium on COVID-19 vaccines. They recommend that the vaccine be contraindicated, especially for women of reproductive age, who are already at higher risk for thrombotic events due to physiological factors.
The alarming data presented in this study follows several other reports of severe side effects associated with the COVID-19 vaccines. Research by Rancourt et al. estimated that 17 million deaths could be linked to COVID-19 vaccines by September 2023. Additionally, a report by Mostert et al. suggested that 3.1 million excess deaths occurred due to vaccination and lockdown policies in 47 Western countries from 2020 to 2022.
The study calls for immediate action, emphasizing the need for further research to understand the underlying mechanisms behind these adverse events. Public health agencies and governments are urged to reconsider their stance on the COVID-19 vaccine in light of these findings.
The study’s authors conclude that the observed increase in cerebral thromboembolic events warrants an urgent reevaluation of the COVID-19 vaccine’s safety profile, particularly for vulnerable populations.